Does EVOLOCUMAB Cause Hyperhidrosis? 397 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 397 reports of Hyperhidrosis have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.3% of all adverse event reports for EVOLOCUMAB.
397
Reports of Hyperhidrosis with EVOLOCUMAB
0.3%
of all EVOLOCUMAB reports
1
Deaths
38
Hospitalizations
How Dangerous Is Hyperhidrosis From EVOLOCUMAB?
Of the 397 reports, 1 (0.3%) resulted in death, 38 (9.6%) required hospitalization, and 6 (1.5%) were considered life-threatening.
Is Hyperhidrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 397 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Hyperhidrosis?
DULOXETINE (4,101)
ADALIMUMAB (2,745)
SODIUM (2,444)
VENLAFAXINE (1,932)
LEVOTHYROXINE (1,856)
ACETAMINOPHEN (1,578)
ETANERCEPT (1,521)
MORPHINE (1,438)
GABAPENTIN (1,408)
PREGABALIN (1,385)
Which EVOLOCUMAB Alternatives Have Lower Hyperhidrosis Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE